Zheng, Chunxing
Snow, Bryan E.
Elia, Andrew J.
Nechanitzky, Robert
Dominguez-Brauer, Carmen
Liu, Shaofeng
Tong, Yin
Cox, Maureen A.
Focaccia, Enrico
Wakeham, Andrew C.
Haight, Jillian
Tobin, Chantal
Hodgson, Kelsey
Gill, Kyle T.
Ma, Wei
Berger, Thorsten
Heikenwälder, Mathias http://orcid.org/0000-0002-3135-2274
Saunders, Mary E.
Fortin, Jerome
Leung, Suet Yi http://orcid.org/0000-0001-8614-4619
Mak, Tak W. http://orcid.org/0000-0001-6766-861X
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (143268, 488053)
Cancer Research Institute
Article History
Received: 28 September 2021
Accepted: 26 July 2023
First Online: 28 August 2023
Competing interests
: T.M. owns equity in Treadwell Therapeutics, Inc., and Agios Pharmaceuticals and is a consultant for AstraZeneca. All other authors have no competing interests.